Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

US Patent 7799832 · Granted Sep 21, 2010

Estimated economic value: $16,900,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating underlying inflammation from COPD or asthma2020
Combinations of flupirtine and sodium channel inhibiting substances for treating2013
Combinations of flupirtine and sodium channel inhibiting substances for treating2013
Combinations of flupirtine and sodium channel inhibiting substances for treating2013
Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leu2013
Combination of anticholinergics and leukotriene receptor antagonists for the tre2012
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for t2012
Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of2011
Treatment of colorectal polyps with imidazoquinoline derivatives2011
Combination of anticholineric and β mimetics for the treatment of respiratory di2011
Indolyl-3-glyoxylic acid derivatives having antitumor action2009
Indolyl-3-glyoxylic acid derivatives having antitumor action2009